Endoscopic Submucosal Dissection Market

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the endoscopic submucosal dissection market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Interviews: Supply-Side Participants- by Company Type, Designation, and Region

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Breakdown of Primary Interviews: Demand-Side Participants by End-User, Designation, and Region

Note: Others include department heads, research scientists, and professors.

Market Size Estimation

The total size of the endoscopic submucosal dissection market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Objectives of the Study

• To describe, analyze, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
• To describe and forecast the endoscopic submucosal dissection market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
• To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the endoscopic submucosal dissection market
• To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
• To profile key players and comprehensively analyze their market shares and core competencies in the endoscopic submucosal dissection market
• To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the endoscopic submucosal dissection market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

• Further breakdown of the RoE endoscopic submucosal dissection market into Austria, Finland, and others
• Further breakdown of the Latin America endoscopic submucosal dissection market into Brazil, Mexico, Argentina, Colombia, Chile, and others

Competitive Landscape Assessment

Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the endoscopic submucosal dissection market

• Competitive leadership mapping for established players in the US

Key areas which can be focused in the ESD endoscopy market by a CEO in the Business Strategy

Market analysis: The CEO would need to analyze the market to understand the size, growth rate, and competitive landscape. This would involve identifying key trends and drivers in the market, as well as potential opportunities and threats.

Product development: The CEO would need to consider the company's product portfolio and identify areas for potential expansion or improvement. This might involve developing new products or features that meet the needs of customers or address unmet needs in the market.

Sales and marketing: The CEO would need to develop a sales and marketing strategy to drive growth and increase market share. This might involve investing in advertising, attending trade shows, or partnering with other companies to reach new customers.

Partnerships and collaborations: The CEO might also consider partnering with other companies to expand the company's capabilities or enter new markets. For example, the company might partner with a medical device manufacturer to develop new products or with a healthcare provider to expand distribution channels.

Some recent examples of growth strategies in the ESD endoscopy market include

Product innovation: Companies such as Olympus, Pentax Medical, and Fujifilm have introduced new products that offer advanced features such as high-definition imaging, advanced visualization, and artificial intelligence (AI) capabilities.

Mergers and acquisitions: In 2020, Boston Scientific acquired the majority stake in Preventice Solutions, a provider of remote monitoring and diagnostics for cardiac arrhythmias. This acquisition expanded Boston Scientific's capabilities in digital health and remote patient monitoring, which could be leveraged in the ESD endoscopy market.

Partnerships and collaborations: In 2019, Cook Medical and Taewoong Medical formed a strategic partnership to expand their product portfolios and market presence in the ESD endoscopy market. The partnership leveraged Cook Medical's expertise in endoscopic devices and Taewoong Medical's expertise in stents and other medical devices.

Top use cases including existing and futuristic for ESD endoscopy market

• Early detection and diagnosis of gastrointestinal cancers
• Treatment of early-stage gastrointestinal cancers
• Removal of precancerous polyps
• Endoscopic resection of gastrointestinal tumors
• Management of gastrointestinal bleeding
• Treatment of esophageal strictures
• Treatment of achalasia
• Removal of foreign bodies from the gastrointestinal tract
• Treatment of inflammatory bowel disease
• Endoscopic sleeve gastroplasty for weight loss
• Endoscopic treatment of gastroesophageal reflux disease (GERD)
• Endoscopic retrograde cholangiopancreatography (ERCP) for the treatment of biliary and pancreatic disorders
• Endoscopic ultrasound for the diagnosis and staging of gastrointestinal cancers
• Endoscopic mucosal resection (EMR) for the removal of benign and early-stage malignant tumors
• Endoscopic submucosal tunneling for the treatment of submucosal tumors
• Endoscopic dilation for the treatment of gastrointestinal strictures
• Endoscopic injection of botulinum toxin for the treatment of achalasia
• Endoscopic placement of stents for the treatment of gastrointestinal strictures and obstructions
• Endoscopic hemostasis for the treatment of gastrointestinal bleeding
• Endoscopic band ligation for the treatment of esophageal varices
• Endoscopic submucosal dissection (ESD) for the removal of early-stage gastrointestinal cancers
• Endoscopic mucosal ablation for the treatment of Barrett's esophagus
• Endoscopic radiofrequency ablation for the treatment of Barrett's esophagus and early-stage esophageal cancers
• Endoscopic cryotherapy for the treatment of early-stage esophageal cancers
• Endoscopic full-thickness resection for the removal of gastrointestinal tumors
• Endoscopic submucosal tunneling with endoscopic closure for the treatment of gastrointestinal perforations
• Endoscopic suturing for the closure of gastrointestinal perforations and leaks
• Endoscopic ultrasound-guided ablation for the treatment of pancreatic and biliary tumors
• Endoscopic ultrasound-guided drainage for the treatment of pancreatic pseudocysts and abscesses
• Endoscopic ultrasound-guided gastrojejunostomy for the treatment of gastric outlet obstruction
• Endoscopic ultrasound-guided portal pressure measurement for the diagnosis of portal hypertension
• Endoscopic mucosal resection with cap-assisted aspiration for the removal of large colorectal polyps
• Endoscopic ultrasound-guided fine needle aspiration for the diagnosis of pancreatic and biliary tumors
• Endoscopic ultrasound-guided fiducial marker placement for the delivery of stereotactic radiotherapy
• Endoscopic submucosal dissection with en bloc retrieval for the diagnosis of submucosal tumors
• Endoscopic removal of intraluminal cysts
• Endoscopic treatment of esophageal diverticula
• Endoscopic treatment of Zenker's diverticulum
• Endoscopic mucosal resection with underwater endoscopic mucosal resection for the removal of rectal lesions
• Endoscopic ultrasound-guided gastroenterostomy for the treatment of malignant gastric outlet obstruction
• Endoscopic ultrasound-guided biliary drainage for the treatment of obstructive jaundice
• Endoscopic ultrasound-guided pancreatic duct drainage for the treatment of pancreatic duct obstruction
• Endoscopic ultrasound-guided hepaticogastrostomy for the treatment of bile duct obstruction

Niche threats/restraints for ESD Endoscopy Business in enterprise?

While the ESD (Endoscopic Submucosal Dissection) endoscopy market presents several growth opportunities, there are also some potential threats and restraints that could affect the business. Here are some of the niche threats and restraints for ESD endoscopy business in enterprise

• High cost of ESD procedures compared to conventional endoscopic procedures
• Limited availability of skilled endoscopists who can perform ESD procedures
• Potential complications associated with ESD procedures, such as perforation, bleeding, and post-procedural stricture formation
• Lack of reimbursement coverage for ESD procedures in some regions
• Competition from alternative treatment options, such as laparoscopic or open surgical procedures
• Stringent regulatory requirements for ESD devices and procedures, which may limit product innovation and development
• Ethical and legal concerns around performing ESD procedures on elderly or high-risk patients
• Limited awareness among patients and healthcare providers about the benefits of ESD procedures, which may impact adoption rates
• Challenges in maintaining high-quality endoscopic imaging and visualization during ESD procedures, which may affect clinical outcomes
• Limited access to advanced endoscopic equipment and technologies in some regions, which may affect the ability to perform ESD procedures safely and effectively.

Recent examples of niche threats/restraints for ESD endoscopy business in enterprise

Lack of reimbursement coverage: In the United States, ESD procedures are not covered by Medicare, which is the largest health insurance provider in the country. This limits access to ESD procedures for many patients, and may also affect the profitability of ESD endoscopy businesses. However, some private insurance providers are starting to cover ESD procedures, which may help to improve access and reimbursement.

Regulatory requirements: In Japan, which is one of the largest markets for ESD endoscopy, regulatory requirements for ESD devices and procedures are becoming increasingly stringent. This has led to delays in device approvals and may also limit the ability of companies to innovate and develop new ESD technologies.

Competition from alternative treatment options: In some cases, laparoscopic or open surgical procedures may be a more effective or cost-efficient treatment option than ESD. This competition can limit the adoption of ESD procedures and may also impact the profitability of ESD endoscopy businesses.

Limited availability of skilled endoscopists: ESD procedures require a high level of technical skill and experience, which may limit the availability of skilled endoscopists who can perform these procedures. This can be a barrier to entry for new ESD endoscopy businesses, and may also limit the growth of existing businesses.

Ethical and legal concerns: In some cases, performing ESD procedures on elderly or high-risk patients may raise ethical and legal concerns around patient safety and informed consent. This can limit the adoption of ESD procedures and may also lead to negative publicity for ESD endoscopy businesses.